The Veteran’s Guide to Psychedelics with Matt Zemon | MDMA, Psilocybin, PTSD & Healing Beyond Antidepressants

The Veteran’s Guide to Psychedelics with Matt Zemon | MDMA, Psilocybin, PTSD & Healing Beyond Antidepressants

In this powerful and heartfelt episode, I sit down with Matt Zemon, author, educator, and advocate for veteran mental health, to discuss psychedelics as a catalyst — not a cure — for deep healing.

We explore the staggering mental health crisis facing veterans, including the reality that between 18–44 veterans die by suicide each day. While traditional antidepressants and talk therapy help many, they do not help everyone. So what do we do for those living with treatment-resistant PTSD, depression, addiction, or traumatic brain injury?

Matt shares:

• His unexpected journey into psychedelics
• The life-changing experience that shifted his worldview
• Why psychedelics reduce shame, blame, and guilt
• The difference between biochemical treatment and psycho-spiritual transformation
• The importance of source, set, and setting for safety
• Why integration is where the real work begins
• How nonprofits are serving veterans through psychedelic retreats
• The collaborative future between medicine and spirituality

We also discuss end-of-life care, MDMA-assisted therapy for cancer patients and loved ones, risk reduction strategies, SSRI tapering considerations, and the importance of medical and spiritual collaboration in this emerging field.

This episode is about responsibility, discernment, and remembering who we truly are.

Moments That Stuck With Me

• “Psychedelics are a catalyst, not a cure.”
• The reminder that antidepressants work for some — but not enough.
• The staggering statistic: more veterans have died by suicide since 9/11 than were killed in combat.
• Source. Set. Setting. — risk reduction as sacred responsibility.
• “The process starts the moment you begin thinking about it.”
• Psychedelics as a flashpoint — not the destination.
• The first 30 days after ceremony as a window of neuroplastic opportunity.
• Not chasing the experience — practicing the integration.
• The idea that these medicines help us see ourselves as magic.
• Collaboration between medical professionals and spiritual guides as the future of safe psychedelic care.
• End-of-life ceremonies as healing not just for the dying — but for the family witnessing.

Key Themes

• Veteran suicide and treatment-resistant PTSD
• MDMA and psilocybin research
• Ayahuasca and ceremonial healing
• Risk reduction and informed consent
• Medical + spiritual collaboration
• Neuroplasticity and integration
• Trauma and meaning-making
• End-of-life psychedelic care
• Family healing and conscious communication
• Community and spiritual practice